A new market research report by Transparency Market Research on the global testosterone replacement therapy market offers an overview of the current scenario of the market and points out the key factors affecting the growth of the market in the near future. The report, titled "Testosterone Replacement Therapy (NYSEMKT:TRT) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2012 - 2018," projects the size and valuation of the global testosterone replacement therapy market during the period between 2012 and 2018. The report further studies the market on the basis of type of product and region. Profiles of some of the key players in the global testosterone replacement therapy market have been included in the report.
Get Report Sample and Customization:
Testosterone replacement therapy , also known as androgen replacement therapy (NYSE:ART), refers to the process of administering testosterone in conditions where the testes are unable to produce sufficient testosterone due to absence, damage, or injury. In the last ten years, the therapy has gained momentum to counter the effects of male hypogonadism. The therapy is usually administered by injecting testosterone or through testosterone skin creams or gels.
The growing awareness about hypogonadism and the rapid growth of the geriatric population have propelled the demand for testosterone replacement therapy. The rise in disposable income has also augmented the growth of the global testosterone replacement therapy market. The therapy is expected to be more in demand during the forecast period with the development of new formulations and strong promotional activities from pharmaceutical companies to educate patients.
On the basis of product type, the report segments the global testosterone replacement therapy market into gels, patches, and others. The gels segment holds the majority of the market. With the introduction of new formulations such as Bio-T-Gel, Axiron, and Androgel 1.62%, the gel segment is expected to grow further.
The report studies the global testosterone replacement therapy market across Asia Pacific, North America, Europe, and Rest of the World. The report takes into consideration the various micro- and macro-economic factors affecting the growth of each of the regional markets. During the forecast horizon, Asia Pacific is expected to register significant growth in the market owing to the presence of an 81-million-strong geriatric population pool in China and India collectively.
Describing the competitive landscape, the report profiles some of the key players in the global testosterone replacement therapy market such as Columbia Laboratories Inc., Endo Pharmaceuticals Inc., Abbott Laboratories, Eli Lilly and Company, Auxilium Pharmaceuticals Inc., Glaxo Smith Kline plc, Kyowa Hakko Kirin Co. Ltd, Bayer Schering Pharma AG, ProStrakan Group PLC., Watson Pharmaceuticals Inc., Trimel BioPharma SRL, Slate Pharmaceuticals Inc., and Acrux Limited.
Full Research Report on Global Testosterone Replacement Therapy Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.